UnitedHealth Group Stock Trades Below Recent Highs Amid Strong Q2 Earnings
UnitedHealth Group Inc., listed on the New York Stock Exchange under ticker US91324P1021, traded at $395.02 as of August 17, 2026, down from its recent peak despite strong second-quarter earnings and guidance for the current year.
The company reported Q2 2026 earnings per share of $6.38, beating consensus expectations by $1.44 or 29.1%, with revenue reaching $112.03 billion, exceeding $110.81 billion in analyst forecasts.
Management has set a full-year EPS guidance range of $19.50 to $20.00 for fiscal 2026, aligning with analyst expectations that cluster around $19.69 in EPS for the current year based on recent research coverage.